TD Cowen Reiterates Buy on TransMedics Group, Maintains $120 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 84.6%

Neg 0% Neu 84.6% Pos 0%

TD Cowen analyst Joshua Jennings reiterates TransMedics Group (NASDAQ:TMDX) with a Buy and maintains $120 price target.

Comments

No comments yet. Be the first!